Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Krystal Biotech, Inc. | d477343d10q.htm |
| EX-31.2 - EX-31.2 - Krystal Biotech, Inc. | d477343dex312.htm |
| EX-31.1 - EX-31.1 - Krystal Biotech, Inc. | d477343dex311.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Krish S. Krishnan, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | the Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Krystal Biotech, Inc. |
| Date: November 13, 2017 | By: | /s/ Krish S. Krishnan | ||||
| Krish S. Krishnan | ||||||
| President and Chief Executive Officer | ||||||
| (Principal Executive Officer) |
I, Antony A. Riley, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | the Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Krystal Biotech, Inc. |
| Date: November 13, 2017 | By: | /s/ Antony A. Riley | ||||
| Antony A. Riley | ||||||
| Chief Financial Officer | ||||||
| (Principal Accounting and Financial Officer) |